HSL Mobile App 
52 week Low
1,317.25
1,317.25
52 week High
1,702.05
1,702.05
1492.60
Day low
1,455.70
1,455.70
Day high
1,496.95
1,496.95
1492.60
Prev Close
1,461.90
1,461.90
Open
1,459.85
1,459.85
6M return
-10.07%
-10.07%
1Y return
1.45%
1.45%
MCap(Rs. in Cr.)
1,18,065.23
1,18,065.23
Total Volume
13,29,904
13,29,904
Face Value : 2
Listed Since
PE Ratio
Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.
P/E RATIO
EPS
The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.
EPS
PRICE/BOOK
Price-to-book ratio is used to compared the company's current market price with its book value.
PRICE/BOOK
Deliverable
These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.
DELIVERABLES
DIV YIELD.(%)
Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.
DIV YIELD.(%)
Company Details
Check out the key parameters of the company to understand the financial health and stock performance
-
Technical
The key levels help you plan your entry and exit point.
-
PROFIT & LOSS
Take a quick look at the revenues and expenditure sheet.
-
Balance Sheet
Its a statement of assets, liabilities and share capital.
-
Dividend History
Check out the detailed payout data over the last three years.
-
Comparative Returns
Reveals how the stock has fared compared to the BSE, NSE benchmark indices.
Key Level
Resistance 1
-
-
Resistance 2
-
-
Support 1
-
-
Support 2
-
-
Moving Average
20 Days
-
-
50 Days
-
-
100 Days
-
-
200 Days
-
-
Growth in 3 years
Sales
Sales Industry Avg
PAT
PAT Industry Avg
Sales Industry Avg
PAT
PAT Industry Avg
Growth in 3 years
Total Asset Growth
NaN%
Total Liabilities growth
NaN%
Reserves Change
NaN%
NaN%
Total Liabilities growth
NaN%
Reserves Change
NaN%
( in Cr.) | ( in Cr.) | ( in Cr.) | ( in Cr.) | ( in Cr.) | |
|---|---|---|---|---|---|
| Entrydate | 09-02-2023 00:00:00 | 23-05-2023 00:00:00 | 06-02-2024 00:00:00 | 16-05-2024 00:00:00 | 07-11-2024 00:00:00 |
| Slno | 28 | 29 | 30 | 31 | 32 |
| Yearenddate | 31-03-2023 00:00:00 | 31-03-2023 00:00:00 | 31-03-2024 00:00:00 | 31-03-2024 00:00:00 | 31-03-2025 00:00:00 |
| Bcloserdate | 28-07-2023 00:00:00 | 26-07-2024 00:00:00 | |||
| Recorddate | 21-02-2023 00:00:00 | 27-07-2023 00:00:00 | 16-02-2024 00:00:00 | 25-07-2024 00:00:00 | 20-11-2024 00:00:00 |
| Exdividenddate | 21-02-2023 00:00:00 | 27-07-2023 00:00:00 | 16-02-2024 00:00:00 | 25-07-2024 00:00:00 | 19-11-2024 00:00:00 |
| Divperc | 250 | 400 | 500 | 250 | 700 |
| Divtype | Interim | Final | Interim | Final | Interim |
250%
Dividend
Date:21 Feb 2023
Dividend Percentage:250
Dividend Type:Interim
400%
Dividend
Date:27 Jul 2023
Dividend Percentage:400
Dividend Type:Final
2023
500%
Dividend
Date:16 Feb 2024
Dividend Percentage:500
Dividend Type:Interim
250%
Dividend
Date:25 Jul 2024
Dividend Percentage:250
Dividend Type:Final
700%
Dividend
Date:19 Nov 2024
Dividend Percentage:700
Dividend Type:Interim
2024 2025
2026
Relative to Sensex rtn in 3 year
Relative to Nifty rtn in 3 year
Relative to top 3 MF rtn in 3 year
Relative to Nifty rtn in 3 year
Relative to top 3 MF rtn in 3 year
| 2016 | 2014 | 2014 | |
|---|---|---|---|
| Sales | 59.91 | 59.91 | 59.91 |
| Gross Profit | 60.14 | 60.14 | 60.14 |
| Operating Profit | 6.14 | 6.14 | 6.14 |
| Sales | 59.91 | 59.91 | 59.91 |
| Gross Profit | 60.14 | 60.14 | 60.14 |
| Operating Profit | 6.14 | 6.14 | 6.14 |
Peer Companies
A quick glance on how stocks from the same sector have performed along with some key parameters
Cipla
1492.60 chg : 30.70 (2.10%)
1492.60 chg : 30.70 (2.10%)
Sun Pharma.Inds.
1704.30 chg : 20.85 (1.24%)
1704.30 chg : 20.85 (1.24%)
Divi`s Lab.
5670.85 chg : 50.40 (0.90%)
5670.85 chg : 50.40 (0.90%)
Torrent Pharma.
3066.35 chg : 10.30 (0.34%)
3066.35 chg : 10.30 (0.34%)
Dr Reddy`s Labs
1150.70 chg : 42.75 (3.86%)
1150.70 chg : 42.75 (3.86%)
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
My investment would be worth with a of %
Our Research Reports
Stocks and sector-wise Research Reports by HDFC securities help you analyse, understand and take a informed investment decision.
Institutional Reports 26 Jan 2022 7:53 AM
Cipla: Cipla’s Q3 results came largely in line with our estimates as strong growth trends in India and the US were partially offset by weak performance in other markets. India business continues to r..
Institutional Reports 28 Oct 2021 7:15 AM
ITC: ITC delivered an in-line revenue growth with a few positives in key segments. Revenue was up 12% YoY with cigarettes/FMCG/hotels/agri/paper growing 10/6/260/-7/25% YoY. Cigarette revenue growth ..
Institutional Reports 27 Oct 2021 9:10 AM
Cipla’s Q2 results were largely in line with estimates as strong growth trends in India, South Africa, and EM markets were partially offset by lower gross margin (~80-100bps impact, inventory provisi..
Report
Corporate Action
Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.
2023
2024
2025
Our Research Analysis
As of today
__PERCENT__%
Target Achived
__PERCENT__%
Target Achived
This call still has potential to give significant positive returns
Potential Upside
__TARGETRETURN__%
Buy Call with __TIMEFRAME__ time frame
CMP : __CMP__
Target : __TARGET__
Stop Loss : __STOPLOSS__
Reco Price : __RECOPRICE__
Reco Date :__RECODATE__
Call Type :__CALLTYPE__
__Rationale__
__RECOTYPE__ __COMPANY_NAME__
|
__DATE__
__MONTHYEAR__ |
Call initiated Target: __TARGET__ |
Target Gain __TG__ % | Reco Price: __RP__ | Stop loss: __SL__ | HORIZON : __HORIZN__ |
Our View __RECOTYPE__
FnO
A snapshot on how the stock has performed in the derivatives segment on a real-time basis.
__Name__ __LTP__ Chg: __ChangePer__ Expiry Month __Date__
Day's Low
__DaysLow__
__DaysLow__
Day's High
__DaysHigh__
__DaysHigh__
Day’s Open
__DaysOpen__
__DaysOpen__
Prev Close
__PreviousClose__
__PreviousClose__
Volume
__Volume__
__Volume__
OI
__OI__
__OI__
OI Change (%)
__OIPer__
__OIPer__
MF Holdings
Here's a list of major funds which hold the stock in their portfolio as of the last reported quarter.
| Scheme Name | AUM (%) | CMV ( in Cr.) | Holding Date |
|---|---|---|---|
| No data available | |||
News
Stay tuned to the latest developments and happenings in the company.
USFDA classifies cGMP inspection of Cipla`s Virgonagar facility as VAI
Cipla has classified its current Good Manufacturing Practices (cGMP) inspection of the company`s manufacturing facility in Virgonagar, Bengaluru, cond....
08 Feb 2025 11:16Cipla to infuse ZAR 900 million in Cipla Medpro South Africa Proprietary Limited
Cipla will invest approx. ZAR 900 million in equity share capital of Cipla Medpro South Africa Proprietary Limited, a wholly-owned subsidiary of the C....
03 Feb 2025 19:20Cipla consolidated net profit rises 48.74% in the December 2024 quarter
Net profit of Cipla rose 48.74% to Rs 1570.51 crore in the quarter ended December 2024 as against Rs 1055.90 crore during the previous quarter ended D....
28 Jan 2025 16:57Cipla to table results
Cipla will hold a meeting of the Board of Directors of the Company on 28 January 2025.Powered by Capital Market - Live News
07 Jan 2025 10:09Cipla consolidated net profit rises 15.18% in the September 2024 quarter
Net profit of Cipla rose 15.18% to Rs 1302.53 crore in the quarter ended September 2024 as against Rs 1130.91 crore during the previous quarter ended ....
29 Oct 2024 15:32Cipla consolidated net profit rises 18.27% in the June 2024 quarter
Net profit of Cipla rose 18.27% to Rs 1177.64 crore in the quarter ended June 2024 as against Rs 995.70 crore during the previous quarter ended June 2....
26 Jul 2024 16:06__heading__
Published on __date__ at __time__
__description__
